West Pharmaceutical Services stock rallies 3.03% on weak market day

9 articles · Updated · MarketWatch · May 7

The shares closed at $322.01 on Thursday, while the S&P 500 fell 0.38% and the Dow Jones Industrial Average dropped 0.63%.
It was West's third straight daily gain and left the stock just 0.10% below its 52-week high of $322.34 reached on 23 October.
Trading volume reached 1.5 million shares, above its 50-day average, as peer moves were mixed with gains for Abbott, Becton Dickinson and Baxter.

West Pharmaceutical's stock is soaring on GLP-1 drug demand. Is its sky-high valuation a dangerous bubble for investors?

With weight-loss drugs shifting to oral pills, can injectable-focused West Pharmaceutical survive the market's next big evolution?